Healthcare

Health is a sustainability issue

Rare and neglected diseases remain a serious problem in our modern world, despite advances in science and technology. Big pharmaceutical companies don't fund research and development into treatments for these diseases because they aren't profitable. The drugs end up costing much more to make than they'll earn back, so they remain un- or underfunded.

Each rare disease affects relatively few people, so the market is too small to make a profit on treatments. Neglected diseases affect about 1 billion people, but most are in underdeveloped, tropical countries. So, although the market is big, treatments are a poor return on investment because the countries can't afford to pay for them.

What is ethical in medicine?

Recently a 57-year-old man received a breakthrough operation. He was bedridden for several months and desperately needed a heart transplant. However, he had several health conditions which made him not suitable for the operation. In a last attempt to save the patient’s life, the Food and Drug Administration gave permission to attempt a genetically modified pig heart transplant for the first time in history. 

The operation was successful. Not only was the patient saved, but the medicine came closer to solving the problem of organ shortages. Unfortunately, the story is not as happy as it might seem.

Visuals: Kids and vaccines

Vaccines can be a controversial issue in some cultures. For instance, according to the Washington Post, in the United States, 9 per cent of adults oppose vaccinating children against measles. Also, many people believe that the coronavirus vaccines are not safe.

Countries have different policies regarding whether it should be mandatory to vaccinate children. Have a look at the map below and discuss what you see with your teacher.

Visuals: COVID-19 vaccination rates

Vaccination against the COVID-19 virus started in December 2020. It has progressed at an unequal rate around the world. As of late April 2021, only a few million people had received a vaccination in the whole of the African continent, while over 200 million Americans had been vaccinated.

However, for some smaller countries, the situation can change very quickly.

Please take a look at the graph below and discuss what you see with your teacher. 

Who will care for Japan's elderly?

Today, more than a quarter of Japan's population is aged over 65. This is set to increase to 40% by 2055. The Ministry of Health, Labour and Welfare has warned that Japan will need to add one million nurses and care workers by 2025 to cope with this demographic change.

Encouraging immigration may seem like a simple solution—but it's not a popular one. Japan is still one of the most ethnically homogeneous countries in the world, with foreigners making up less than 2% of the population. Opening up Japan to large-scale immigration is a very sensitive subject.

Nurses on Instagram: nursefluencers

Sarah’s Instagram feed is pretty typical for a 21-year-old model-slash-influencer living in Florida. There’s one important difference: In all of her pictures, she’s wearing scrubs.

Being a "nursefluencer," a term that I have admittedly made up but that describes a growing population, is similar to being a regular influencer.

For Sarah, and many young health care professionals like her, a sizeable Instagram following is a salve for a litany of problems experienced by those in the field: burnout, odd hours, and a lack of a creative outlet, to start. So it’s not surprising that within the past few months, tons of accounts like hers have popped up, gaining huge followings — largely made up of fellow medical professionals — by posting an insider’s view of the industry.

It’s also raised questions about the ethics of being a health care influencer. After all, isn’t the only person who should be influencing anyone’s health their own doctor?

American & Japanese win Nobel prize

Two scientists who discovered how to harness the body’s immune system to fight cancer won the 2018 Nobel prize in physiology or medicine. James Allison, of the US, and Tasuku Honjo, of Japan, shared the 9m Swedish kronor ($1m/¥113m) prize.

The scientists’ groundbreaking work on the immune system has paved the way for a new class of cancer drugs that are already dramatically changing outcomes for patients. It is the first time the development of a cancer therapy has been recognised with a Nobel prize.

Allison said he was in a “state of shock” about having achieved “every scientist’s dream”. “I’d like to give a shout out to all the [cancer] patients out there to let them know we’re making progress here,” he said.

Honjo, who began his research after a medical school classmate died from stomach cancer, said: “I want to continue my research...so that this immune therapy will save more cancer patients than ever.”

Hospitals' troubles with tourism

The number of tourists to Japan has more than quadrupled since 2009, and the government aims to boost that figure to 40 million by 2020 and 60 million by 2030. But the growing influx is likely to put a greater strain on Japan’s hospitals as many patients from overseas arrive without insurance and are unable to pay for treatment. 

The problem is not limited to cost, however. Communication is also a hurdle, both at hospitals and especially small clinics. While some facilities can conduct treatment in foreign languages, many can only do so in English or Chinese.

Tokyo Medical University scandal

A Japanese medical school has been accused of manipulating the test scores of female applicants for years to artificially depress the number of women in the student body, a scandal that has triggered sharp criticism.

The revelations have highlighted institutional barriers that women in Japan still face as they pursue work in fields that have long been dominated by men.

Tokyo Medical University reduced the test scores of women to keep their numbers at about 30 percent of entering classes. For the 2018 school year, 8.8 percent of men and 2.9 percent of women were accepted, according to the Yomiuri Shimbun newspaper.

The newspaper quoted an unnamed source as saying that school administrators justified the practice out of the belief that women were more likely to drop out of the profession after marriage or childbirth.

Software will replace doctors

According to Keith Rabois, a Khosla Ventures partner and former executive at LinkedIn, PayPal, and Square, areas that require human expert judgment, like healthcare and law, are most likely to see disruption in the coming years.

"One of the most interesting things we’ve noticed over the last decade is the ability of math and machines to replace human judgment, particularly expert judgment," Rabois said on Founder Calls, a new podcast run by Box CEO Aaron Levie.

"And it’s finally possible now to use data and machine learning techniques to replace the judgment of experts in law and in healthcare," he said.